Date	Name	Title	Type	Shares Traded	Price Range
Jul 25, 2008	bloch stephen m	Director	Automatic Sell	2,300	15.43
Aug 1, 2008	crowley john f	Officer	Automatic Sell	3,800	15.42 - 15.43
Jul 29, 2008	bloch stephen m	Director	Automatic Sell	3,600	15.30
Dec 3, 2007	dentzer james e	Officer	Disposition (Non Open Market)	220	15.30
Jul 24, 2008	bloch stephen m	Director	Automatic Sell	5,661	15.24
Aug 4, 2008	bloch stephen m	Director	Automatic Sell	4,500	15.23
Jul 28, 2008	bloch stephen m	Director	Automatic Sell	9,000	15.23
Aug 4, 2008	crowley john f	Officer	Automatic Sell	6,200	15.22 - 15.27
Jul 30, 2008	bloch stephen m	Director	Automatic Sell	4,700	15.19
Aug 18, 2008	licholai gregory p	Officer	Sell	1,401	15.11
Oct 1, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	15.10
Oct 1, 2008	crowley john f	Officer	Automatic Sell	1,400	15.08 - 15.08
Jul 28, 2008	palling david	Officer	Automatic Sell	2,500	15.08
Oct 2, 2008	crowley john f	Officer	Automatic Sell	2,600	15.06 - 15.13
Sep 29, 2008	palling david	Officer	Automatic Sell	2,500	15.03 - 16.22
Aug 18, 2008	patterson matthew r	Officer	Automatic Sell	3,500	15.02 - 16.04
Jul 22, 2008	bloch stephen m	Director	Automatic Sell	8,589	15.01
Jun 5, 2007	barkas alexander e	Director	Sell	6,427	15.00
Jun 5, 2007	barris peter j	Beneficial Owner (10% or more)	Sell	6,408	15.00
Jun 5, 2007	kramlich c richard	Beneficial Owner (10% or more)	Sell	6,408	15.00
Showing 21-40 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.